Search research articles
Contact Us
Filters
Showing results (381-390 of 483) with videos related to
Page
of 49
Sort By:
International Journal of Hematology
|
November 19, 2021
Safety and efficacy of durvalumab with R-CHOP or R<sup>2</sup>-CHOP in untreated, high-risk DLBCL: a phase 2, open-label trial
Grzegorz S Nowakowski, Wolfgang Willenbacher, Richard Greil, et al.
Journal of Leukocyte Biology
|
December 10, 2021
Kindlin-3 maintains marginal zone B cells but confines follicular B cell activation and differentiation
Andrea Härzschel, Lixia Li, Peter W Krenn, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 5, 2013
Randomized phase II study of the anti-epidermal growth factor receptor monoclonal antibody cetuximab with cisplatin versus cisplatin alone in patients with metastatic triple-negative breast cancer
José Baselga, Patricia Gómez, Richard Greil, et al.
American Journal of Hematology
|
December 30, 2014
Molecular responses and chromosomal aberrations in patients with polycythemia vera treated with peg-proline-interferon alpha-2b
Nicole C C Them, Klaudia Bagienski, Tiina Berg, et al.
European Journal of Cancer (Oxford, England : 1990)
|
April 22, 2025
Pembrolizumab with or without chemotherapy in recurrent or metastatic head and neck squamous cell carcinoma: 5-year follow-up from the randomized phase III KEYNOTE-048 study
Makoto Tahara, Richard Greil, Danny Rischin, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 25, 2012
Tamoxifen and anastrozole as a sequencing strategy: a randomized controlled trial in postmenopausal patients with endocrine-responsive early breast cancer from the Austrian Breast and Colorectal Cancer Study Group
Peter C Dubsky, Raimund Jakesz, Brigitte Mlineritsch, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 13, 2011
Eight cycles of escalated-dose BEACOPP compared with four cycles of escalated-dose BEACOPP followed by four cycles of baseline-dose BEACOPP with or without radiotherapy in patients with advanced-stage hodgkin's lymphoma: final analysis of the HD12 trial of the German Hodgkin Study Group
Peter Borchmann, Heinz Haverkamp, Volker Diehl, et al.
Haematologica
|
April 26, 2015
Rituximab maintenance for patients with aggressive B-cell lymphoma in first remission: results of the randomized NHL13 trial
Ulrich Jaeger, Marek Trneny, Helen Melzer, et al.
JAMA
|
November 9, 2016
Effect of Tailored Dose-Dense Chemotherapy vs Standard 3-Weekly Adjuvant Chemotherapy on Recurrence-Free Survival Among Women With High-Risk Early Breast Cancer: A Randomized Clinical Trial
Theodoros Foukakis, Gunter von Minckwitz, Nils-Olof Bengtsson, et al.
Journal of Medical Internet Research
|
March 7, 2025
Augmenting Insufficiently Accruing Oncology Clinical Trials Using Generative Models: Validation Study
Samer El Kababji, Nicholas Mitsakakis, Elizabeth Jonker, et al.
Page
of 49
Search research articles
Search
Showing results (381-390 of 483) with videos related to
Sort By:
Page
of 49
International Journal of Hematology
|
November 19, 2021
Safety and efficacy of durvalumab with R-CHOP or R<sup>2</sup>-CHOP in untreated, high-risk DLBCL: a phase 2, open-label trial
Grzegorz S Nowakowski, Wolfgang Willenbacher, Richard Greil, et al.
Journal of Leukocyte Biology
|
December 10, 2021
Kindlin-3 maintains marginal zone B cells but confines follicular B cell activation and differentiation
Andrea Härzschel, Lixia Li, Peter W Krenn, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 5, 2013
Randomized phase II study of the anti-epidermal growth factor receptor monoclonal antibody cetuximab with cisplatin versus cisplatin alone in patients with metastatic triple-negative breast cancer
José Baselga, Patricia Gómez, Richard Greil, et al.
American Journal of Hematology
|
December 30, 2014
Molecular responses and chromosomal aberrations in patients with polycythemia vera treated with peg-proline-interferon alpha-2b
Nicole C C Them, Klaudia Bagienski, Tiina Berg, et al.
European Journal of Cancer (Oxford, England : 1990)
|
April 22, 2025
Pembrolizumab with or without chemotherapy in recurrent or metastatic head and neck squamous cell carcinoma: 5-year follow-up from the randomized phase III KEYNOTE-048 study
Makoto Tahara, Richard Greil, Danny Rischin, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 25, 2012
Tamoxifen and anastrozole as a sequencing strategy: a randomized controlled trial in postmenopausal patients with endocrine-responsive early breast cancer from the Austrian Breast and Colorectal Cancer Study Group
Peter C Dubsky, Raimund Jakesz, Brigitte Mlineritsch, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 13, 2011
Eight cycles of escalated-dose BEACOPP compared with four cycles of escalated-dose BEACOPP followed by four cycles of baseline-dose BEACOPP with or without radiotherapy in patients with advanced-stage hodgkin's lymphoma: final analysis of the HD12 trial of the German Hodgkin Study Group
Peter Borchmann, Heinz Haverkamp, Volker Diehl, et al.
Haematologica
|
April 26, 2015
Rituximab maintenance for patients with aggressive B-cell lymphoma in first remission: results of the randomized NHL13 trial
Ulrich Jaeger, Marek Trneny, Helen Melzer, et al.
JAMA
|
November 9, 2016
Effect of Tailored Dose-Dense Chemotherapy vs Standard 3-Weekly Adjuvant Chemotherapy on Recurrence-Free Survival Among Women With High-Risk Early Breast Cancer: A Randomized Clinical Trial
Theodoros Foukakis, Gunter von Minckwitz, Nils-Olof Bengtsson, et al.
Journal of Medical Internet Research
|
March 7, 2025
Augmenting Insufficiently Accruing Oncology Clinical Trials Using Generative Models: Validation Study
Samer El Kababji, Nicholas Mitsakakis, Elizabeth Jonker, et al.
Page
of 49